Navigation Links
Oxford Finance Closes $25 Million Senior Credit Facility with Entellus Medical
Date:1/8/2014

ALEXANDRIA, Va., Jan. 8, 2014 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it entered into a term loan agreement with Entellus Medical, Inc. that expanded the original $17 million loan facility to $25 million. Entellus is using proceeds of the loan to support business operations and the ongoing marketing efforts for its minimally invasive treatments for chronic sinusitis.

"Entellus has impressed the medical community with its quality solutions for treating patients with sinusitis," said Christopher A. Herr, managing director for Oxford Finance. "We are pleased to provide financial support to the company as it continues to grow revenues and increase market share."

"Oxford has been a valued and reliable financial partner for Entellus," said Thomas E. Griffin, chief financial officer for Entellus Medical. "They understand our industry and support our primary business goal, which is to bring highly efficacious and cost-saving sinusitis treatments to patients in the convenience of the doctor's office."

About Oxford Finance LLC

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life science and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $2 billion in loans, with lines of credit ranging from $500 thousand to $50 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Illinois, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.  

About Entellus Medical, Inc.

Entellus Medical provides complete solutions for the minimally invasive treatment of chronic and recurrent sinusitis patients and is leading the way with easy-to-use, cost-effective products designed for office-based balloon dilation of narrowed sinus pathways. With this approach, Entellus sinus dilation products also provide significant efficiency and cost-effectiveness for sinus dilation procedures performed in operating rooms. For more information on XprESS™ Multi-Sinus Dilation Tool, FinESS™ Sinus Treatment, or PathAssist™ sinus confirmation tools visit www.EntellusMedical.com.


'/>"/>
SOURCE Oxford Finance LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
2. Senate Finance Committee Addresses Problem-Plagued Medicare Bidding Program in SGR Bill
3. Genpact and AstraZeneca Extend Finance and Accounting Services Agreement
4. Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development
5. Regeneron Announces Appointment of Robert E. Landry as Senior Vice President, Finance and Chief Financial Officer
6. Michael A. Jacobsen Joining Omeros as Vice President, Finance and Chief Accounting Officer
7. Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities
8. Horizon Technology Finance Closes $2 Million Venture Loan Facility with New Haven Pharmaceuticals
9. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
10. Invuity Bolsters Executive Team; Adds Industry Veterans in Key Finance and Commercial Roles
11. McGuireWoods and McGladrey Present 10th Annual Healthcare and Life Sciences Private Equity and Finance Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... April 29, 2016 ... Financier Sanofi, leader mondial ... ses résultats pour le premier trimestre ... Jérôme Contamine, commente les résultats du ... perspectives pour le reste de l,année. ...
(Date:4/29/2016)... April 29, 2016 Automation is ... laboratory due to the growing demands for productivity in ... contemporary automated systems are already adept of a wide ... tedious and manual labor. Instrumentation continues to evolve, and ... conceivable just a few years ago. Originally used mostly ...
(Date:4/28/2016)...  While Abbott,s announced purchase of St. Jude ... and stent business, healthcare research firm Kalorama Information ... into patient monitoring.  Kalorama said that patient monitoring ... with double-digit growth expected the next 5 years, ... Patient Monitoring . Abbott Laboratories agreed to ...
Breaking Medicine Technology:
(Date:4/30/2016)... Indianapolis, Indiana (PRWEB) , ... April 30, 2016 , ... ... USA Wrestling as they go for gold in Rio. Under the care of ... including two golds! , In an unprecedented showing, Maximized Living is sending the largest ...
(Date:4/29/2016)... Hollywood, Fl (PRWEB) , ... April 29, 2016 ... ... was recently notified by the Accreditation Council for Graduate Medical Education (ACGME) that ... , This is the first accreditation of three residency programs that Memorial ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... optimistic healthcare awareness and author of best seller "LOVE, MEDICINE and MIRACLES") addresses ... Monday, May 2, 2016 and podcasted thereafter . Dr. Bernie Siegel, author ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Spine Team Texas, ... is proud to announce one of their physicians has been invited to be a ... (Texas ACOFP) Family Practice Review conference on April 30, 2016. , Dr. R. ...
(Date:4/29/2016)... ... ... type of skin cancer. Although only about 1 percent of skin cancer cases are melanoma, ... are expected to die of melanoma this year. The risk increases with age, and while ... diagnosed cancers in young women. A recent breakthrough in genetic studies may give doctors the ...
Breaking Medicine News(10 mins):